找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte

[復(fù)制鏈接]
樓主: 指責
21#
發(fā)表于 2025-3-25 05:03:52 | 只看該作者
22#
發(fā)表于 2025-3-25 08:41:54 | 只看該作者
23#
發(fā)表于 2025-3-25 11:44:58 | 只看該作者
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
24#
發(fā)表于 2025-3-25 17:22:12 | 只看該作者
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
25#
發(fā)表于 2025-3-25 22:26:03 | 只看該作者
26#
發(fā)表于 2025-3-26 00:57:08 | 只看該作者
27#
發(fā)表于 2025-3-26 04:37:57 | 只看該作者
28#
發(fā)表于 2025-3-26 08:42:03 | 只看該作者
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
29#
發(fā)表于 2025-3-26 13:37:23 | 只看該作者
30#
發(fā)表于 2025-3-26 18:28:43 | 只看該作者
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 03:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
井研县| 务川| 祁连县| 太谷县| 庆城县| 北宁市| 民勤县| 阳山县| 观塘区| 巴中市| 阜阳市| 潍坊市| 体育| 丹江口市| 苏州市| 桑日县| 财经| 绥滨县| 凤冈县| 厦门市| 盐津县| 庐江县| 文昌市| 通山县| 丁青县| 林西县| 义马市| 吉隆县| 西乡县| 浮山县| 东阿县| 桃源县| 瓦房店市| 鄢陵县| 连州市| 太仓市| 邮箱| 蒲江县| 山阳县| 安远县| 福州市|